Spencer Phillips/EMBL-EBI

An automated method for cell type discovery

Identifying cell types from single-cell RNA sequencing data is now more efficient than ever

Identifying different types of cells within a tissue or an organ can be very challenging and time-consuming. Methods to identify cell types from single-cell RNA sequencing data have been proposed, but they all fall short in discovering potentially new cell types. Researchers from the Wellcome Sanger Institute and EMBL’s European Bioinformatics Institute (EMBL-EBI) have created a new method called Single Cell Clustering Assessment Framework (SCCAF) that bridges this gap.

Published today (18th May) in Nature Methods, this automated method uses machine learning and can replicate manual, expert annotations that are normally used for this task, and can characterise new cell types.

All somatic cells in a multicellular organism have the same genome, yet they perform a variety of functions. This functional diversity occurs between cells of different types (skin cells and neurons, for instance), but also between states of the same cell lineage as it differentiates.

Historically, researchers have identified cell types or states based on visible features or the expression of a handful of genes. Single-cell RNA sequencing (scRNA-seq) has brought high-throughput gene expression data into the picture.

A cell’s gene expression pattern (which genes are expressed at what level) serves as a proxy for its function and allows scientists to classify or “cluster” that cell with others that have the same function. Until now, annotating cells from scRNA-seq data has required time-consuming human intervention, with automated methods unable to identify cell types or states that had not been previously annotated by human experts.

The researchers came up with a method that uses machine learning to address these challenges.
Single Cell Clustering Assessment Framework (SCCAF) starts by using a clustering algorithm to group the cells of a sample into many clusters, based on their gene expression patterns. Each cell cluster is split into a “training set” and a “testing set” for the second stage of the analysis. A classifying model then takes over, using the training set to learn to distinguish cell clusters, and predicting likely clusters in the testing set. The model’s accuracy is assessed by comparing its prediction with the original clusters.

“The model repeats the training and testing steps for each cell cluster, gradually merging indistinguishable clusters, until its accuracy reaches a good enough level. Finally, our Single Cell Clustering Assessment Framework lists a set of feature genes to characterise each annotated cluster.”
Dr Zhichao Miao, the first author on the paper from EMBL-EBI and the Wellcome Sanger Institute

This Single Cell Clustering Assessment Framework method has been shown to be highly reliable and fast.

“We’ve tested the method on many existing large-scale datasets of human and mouse gene expression, treating human annotation as a gold standard. Our method can reproduce human annotation in an automated manner. By minimising human involvement in data processing, we solve the most important bottleneck in high-throughput projects, such as the Human Cell Atlas.”
Dr Alvis Brazma, a senior author and Functional Genomics Senior Team Leader at EMBL-EBI

Not only does SCCAF reproduce and refine existing cell type classification, it also helps reveal new cell types and states from unannotated samples. The new method will be implemented in large-scale projects, including the Single Cell Expression Atlas and the Human Cell Atlas.

“The Human Cell Atlas initiative is a global consortium to map every cell type in the human body, to understand health and disease. The new automated cell-clustering method will enable us to identify cell types much more easily than before, helping us expand our understanding of cellular function and diversity.”
Dr Sarah Teichmann, a senior author from the Wellcome Sanger Institute, and co-chair of the Human Cell Atlas Organising Committee

Press Contacts

If you need help or have any queries, please contact us.

Emily Mobley
Media Manager
Tel +44 (0)1223 496 851
Email: emily.mobley@sanger.ac.uk

 

Dr Matthew Midgley
Media Officer
Tel +44 (0)1223 494 856
Email: matthew.midgley@sanger.ac.uk

 

Dr Samantha Wynne
Media Officer
Tel +44 (0)1223 492 368
Email: samantha.wynne@sanger.ac.uk

 

Press office
Wellcome Sanger Institute, Hinxton,
Cambridgeshire, CB10 1SA, UK
Tel +44 (0) 7748 379849
Email: press.office@sanger.ac.uk

 

Notes to Editors

Publication:

Zhichao Miao et al. (2020) Putative cell type discovery from single-cell gene expression data. Nature Methods DOI: 10.1038/s41592-020-0825-9

Funding:

This work was supported by Wellcome.

Selected websites

  • EMBL’s European Bioinformatics Institute (EMBL-EBI)

    EMBL’s European Bioinformatics Institute (EMBL-EBI) is a global leader in the storage, analysis and dissemination of large biological datasets. EMBL-EBI helps scientists realise the potential of ‘big data’ by enhancing their ability to exploit complex information to make discoveries that benefit humankind.

    EMBL-EBI is at the forefront of computational biology research, with work spanning sequence analysis methods, multi-dimensional statistical analysis and data-driven biological discovery, from plant biology to mammalian development and disease.

    EMBL-EBI is part of the European Molecular Biology Laboratory (EMBL), an international, innovative and interdisciplinary research organisation funded by 25 member states and two associate member states, and are located on the Wellcome Genome Campus, one of the world’s largest concentrations of scientific and technical expertise in genomics. www.ebi.ac.uk

  • The Wellcome Sanger Institute

    The Wellcome Sanger Institute is a world leading genomics research centre. We undertake large-scale research that forms the foundations of knowledge in biology and medicine. We are open and collaborative; our data, results, tools and technologies are shared across the globe to advance science. Our ambition is vast – we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve health and to understand life on Earth. Find out more at www.sanger.ac.uk or follow us on Twitter, Facebook, LinkedIn and on our Blog.

  • About Wellcome

    Wellcome exists to improve health by helping great ideas to thrive. We support researchers, we take on big health challenges, we campaign for better science, and we help everyone get involved with science and health research. We are a politically and financially independent foundation. wellcome.org